Brief: Iconovo Extends Agreement With Amneal
May 17 (Reuters) - Iconovo AB ICO.ST :
* EXTENDS AGREEMENT WITH AMNEAL
* ACQUIRED LICENSE TO SELL AMNEAL'S GENERIC VERSIONS OF
SYMBICORT
IN NORDIC COUNTRIES WITH POTENTIAL TO GENERATE SEK 80-100
MILLION
* DEAL LEADS TO MORE THAN DOUBLING OF EARLIER COMMUNICATED
POTENTIAL FOR ANNUAL ROYALTY INCOME TO SEK 110 - 220 MILLION
(MUSD 13.2 - 26.4)
Source text: https://cisn.co/2Rmh08g
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))